Pharmacological treatment for patients with ET
Measure purpose: Ensure pharmacological treatment options are routinely discussed.
The numerator: patients for whom pharmacological treatment* options were discussed at least once in the 12-month measurement period
*See measure specifications for complete definitions.
is divided by
The denominator: patients 18 years and older with a diagnosis of essential tremor.
Exclusions are removed from the denominator:
- Patient declines discussion
- Patient is unable to participate in examination (i.e., advanced stage dementia, profound psychosis, neurodevelopmental disorder, brain injury encephalopathy, or hydrocephalus) and caretaker not present
Key Phrases
Examples of key phrases you could use to meet the measure include:
- Discussed pharmacological options
- Pt declines information on pharmacological treatment options
Measure Calculation Example
Dr. Martin sees 100 patients between January 1 and December 31 aged 18 years and older diagnosed with ET. This is the denominator.
Three patients declined to discuss pharmacological treatment options, and five patients were unable to engage in the discussion and did not have a caretaker present. These 8 (5+3) patients are removed from the denominator as they meet exclusion criteria.
Of the 92 patients that qualify for this measure, 37 had documentation of a discussion about pharmacological treatment option in the year. This is the numerator.
Quality of patient care = 37/(100-8). Dr. Martin has a score of 40.2% for this measure.